Cel Sci Corporation (CVM)

[rwa3848]

Any prognostication about the pre-BLA that alleges CVM investor relations as a source is an act of deception relying upon presumptions about the 60 day calendar for an agreed & approved scheduling of the pre-BLA by the FDA. Included within the 60 day pre-BLA calendar is a 21 day window for the scheduled meeting notice letter to arrive. As such, it is wrong to discount CVM's pre-BLA occurring during 2022 until after Thanksgiving. Moreover, investor relations would never be made party to negotiations between CVM & the FDA until SEC reporting required material events happen, because leaks are too litigiously expensive.